home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Evidence Generation: Evolution and Future of Integrated Evidence Planning

  May 15, 2024  
Xtalks, Online

It is increasingly important for the life sciences industry to adopt an integrated approach to planning, generating and managing the evidence required for the value of its innovations. Integrated evidence planning (IEP) is a framework that leverages an ensemble of different data sources, scientific methods and cross-functional expertise across a product’s life cycle to generate key information about its benefits, safety and value most effectively and efficiently.

In this webinar, the expert speaker will provide insights into functional and operational aspects of IEP and the rationale and benefits of IEP. They will discuss the evolution of IEP, future trends and how it meets different stakeholders’ requirements. Attendees will gain insights into the potential barriers to IEP and ways to overcome them, as well as the operational aspects of IEP such as the development, implementation and operationalization of IEP systems.

Join this webinar:

To understand the rationale for integrated evidence generation and the need for evidence beyond randomized controlled trials
To learn the evolution of IEP
To brainstorm on the challenges for IEP and potential solutions to overcome them
To decipher the architecture of IEP systems and processes involved in their development, implementation and operation
To form a forward-looking vision with regards to the emerging innovative trends in IEP
Keywords: Clinical Trials, Clinical Trial Data, Real-World Data, Patient Outcomes, Real-World Evidence, HEOR, RWE, Clinical Trial Endpoints, Data Science, Commercialization/HEOR/Market Access, RWD, Integrated Evidence Generation, Integrated Evidence Planning, Cross-functional Collaboration
Organized by: Xtalks
Invited Speakers: Dr. Won Chan Lee, PhD, Principal and Practice Lead of HEOR/RWE Practice, Axtria – Ingenious Insights
Chris Blanchette, PhD, Vice President, Clinical Data Science & Evidence, Novo Nordisk
Shibani Pokras, Senior Director and Global Process Owner, Integrated Evidence Planning, GSK
Deadline for Abstracts: 2024-05-22
Registration: Free Registration
E-mail: tristan@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.